Recurrent gain-of-function USP8 mutations in Cushing's disease
Top Cited Papers
Open Access
- 13 February 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Research
- Vol. 25 (3), 306-317
- https://doi.org/10.1038/cr.2015.20
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- USP8 Promotes Smoothened Signaling by Preventing Its Ubiquitination and Changing Its Subcellular LocalizationPLoS Biology, 2012
- EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomasJCI Insight, 2011
- Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8·STAM ComplexPublished by Elsevier BV ,2010
- The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromesClinical Genetics, 2010
- Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus StatementJournal of Clinical Endocrinology & Metabolism, 2008
- The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice GuidelineJournal of Clinical Endocrinology & Metabolism, 2008
- 14-3-3-dependent inhibition of the deubiquitinating activity of UBPY and its cancellation in the M phaseExperimental Cell Research, 2007
- Essential Role of Ubiquitin-Specific Protease 8 for Receptor Tyrosine Kinase Stability and Endocytic Trafficking In VivoMolecular and Cellular Biology, 2007
- Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing diseaseGenes & Development, 2006
- Low Expression of the Cell Cycle Inhibitor p27Kip1 in Normal Corticotroph Cells, Corticotroph Tumors, and Malignant Pituitary TumorsJournal of Clinical Endocrinology & Metabolism, 1999